Protocols

Introduction

This kit contains Dynabeads® Protein A and buffers for immunoprecipitation.

Intended Use

This kit is designed for immunoprecipitation of proteins, protein complexes, protein-nucleic acid complexes and other antigens.

Principle

Antibody (Ab) is added to the Dynabeads® Protein A. During a short incubation the Ab will bind to the Dynabeads® via their Fc region. The tube is then placed on a Dynal® magnet, where the beads will migrate to the side of the tube facing the magnet and allow for easy removal of the supernatant. The bead-bound Ab may now be used for immunoprecipitation. Bound material is easily collected utilizing the unique magnetic properties of the Dynabeads®. Magnetic separation facilitates washing, buffer changes and elution.

Description of Materials

Material supplied

  • Dynabeads® Protein A  (2 ml)  These uniform, superparamagnetic beads are 2.8 μm in diameter, and have recombinant Protein A  (approx. 45 kDa) covalently coupled to their surface. The beads are supplied at a concentration of 30 mg/ml in phosphate buffered saline (PBS), pH 7.4, containing 0.01% Tween®-20 and 0.09% sodium azide (NaN3).
  • Ab Binding & Washing Buffer (16 ml)
  • Washing Buffer (28 ml)
  • Elution Buffer (1 ml)


All reagents are of analytical grade. The buffers are compatible with protease/ phosphatase inhibitors, which may be used if required.

Additional Materials Required

  • Magnet: e.g DynaMag™-2 or DynaMag™-Spin (see www.lifetechnologies.com/magnets for further information and magnet recommendations).
  • Mixer allowing rotation of tubes.
  • Cell lysis buffer, e.g. Cell Extraction Buffer (Cat. no. FNN0011) or NP40 Cell Lysis Buffer (Cat. no. FNN0021) from Invitrogen
  • SDS-PAGE sample buffer, e.g. NuPAGE® LDS Sample Buffer (Cat. no. NP0007) and NuPAGE® Sample Reducing Agent (Cat. no. NP0009) from Invitrogen


Antibody selection

The choice of primary antibody is the most important factor for successful target antigen capture. Note that some antibodies may show reduced antigen-binding efficiency for immunoprecipitation, even though the antibody shows good results in other immunological assays. Please refer to the manufacturer’s recommendations regarding your primary antibody.

Protocols

This protocol offers a general guideline for immunoprecipitation. Optimization may be required for each antibody and target antigen. This protocol format uses 50 μl of Dynabeads® Protein G , but may be scaled up or down as required.

Cell lysis

Cells may be lysed using any standard cell lysis protocol compatible with your starting material. We recommend the use of Cell Extraction Buffer or NP40 Cell Lysis Buffer. For protocols and additional information about cell lysis, please see www.lifetechnologies.com/immunoprecipitation.

Preparation of Dynabeads®

  1. Completely resuspend Dynabeads® by pipetting or by rotating on a roller (5 minutes).

  2. Transfer 50 µl (1.5 mg) Dynabeads® to a test tube.

  3. Separate on the magnet until the supernatant is clear and remove the supernatant.

  4. Remove the tube from the magnet.

  5. Proceed directly to Ab-binding.

  6. Binding of Antibody


  7. Add your antibody (typically 1-10 μg Ab), diluted in 200 μl Ab Binding & Washing Buffer, to the tube from step above. The optimal amount of Ab needed will depend upon the individual Ab used.

  8. Incubate with rotation for 10 minutes at room temperature.

  9. Place the tube on the magnet and remove the supernatant.

  10. Remove the tube from the magnet and resuspend the beads in 200 µl Ab Binding & Washing Buffer, wash by gentle pipetting.

  11. Proceed directly to immunoprecipitation.

    Crosslinking

    Should you wish to crosslink your antibody to the Dynabeads® before continuing with immunoprecipitation, we recommend use of the cross-linking reagent BS³ (5 mM) from Thermo Scientific Group (Pierce). For further information and protocol, please visit: www.lifetechnologies.com/crosslinking.

    Immunoprecipitation of Target Antigen


  12. Place the tube (from step 10) on the magnet, and remove the supernatant.

  13. Add your sample containing the antigen (Ag) (typically 100-1,000 µl) and gently pipette to resuspend the Dynabeads®-Ab complex.

  14. Incubate with rotation for 10 minutes at room temperature to allow Ag to bind to the Dynabeads®-Ab complex. Note: Depending on the affinity of the antibody, it may be necessary to increase incubation times for optimal binding.

  15. Place the tube on the magnet. Transfer the supernatant to a clean tube for further analysis, if desired.

  16. Wash the Dynabeads®-Ab-Ag complex three times using 200 μl Washing Buffer for each wash. Separate on the magnet between each wash, remove supernatant and resuspend by gentle pipetting.

  17. Resuspend the Dynabeads®-Ab-Ag complex in 100 μl Washing Buffer and transfer the bead suspension to a clean tube. This is recommended to avoid co-elution of proteins bound to the tube wall.

  18. Proceed to elution

    Elution of Target Antigen

    Alternative protocols A or B:

    Denaturing elution

  19. Place the tube (from step 17) on the magnet and remove the supernatant.

  20. Add 20 µl Elution Buffer and 10 µl premixed NuPAGE LDS Sample Buffer and NuPAGE Sample Reducing Agent (mixed as per manufacturer’s instructions). Gently pipette to resuspend the Dynabeads®-Ab-Ag complex.

  21. Heat for 10 min at 70ºC.

  22. Place the tube on the magnet and load the supernatant/sample onto a gel. Note: As an alternative, the Dynabeads®-Ab-Ag complex can be resuspended in a sample buffer of your choice (e.g. SDS sample buffer). Follow the recommended temperatures and heating times for these buffers prior to gel loading.

    B  Gentle, non-denaturing elution

  23. Place the tube (from step 17) on the magnet and remove the supernatant.

  24. Add 20 µl Elution Buffer and gently pipette to resuspend the Dynabeads®-Ab-Ag complex. Avoid foaming.

  25. Incubate with rotation for 2 minutes at room temperature to dissociate the complex.

  26. Place the tube on the magnet and transfer the supernatant containing eluted Ab and Ag to a clean tube. If the eluted protein is to be used for functional assays or stored, the pH of the eluate can be adjusted by adding 1M Tris, pH 7.5.


Technical Advice

Binding characteristics:

Binding capacity:
Dynabeads® Protein G have a binding capacity of approximately 7 µg human IgG per mg beads. The amount of Ab captured depends on the concentration of Ab and Dynabeads® Protein G in the starting sample.

Ig origin Affinity for protein A Affinity for protein G
Human IgG1,2,4++++++
Human IgD--
Human IgA E, M+-
Human IgG3++++
Mouse IgG1++++
Mouse IgG2a,2b, 3++++++
Mouse IgM++
Rat IgG1++
Rat IgG2a-+++
Rat IgG2b-+
Rat IgG2c++++
Bovine IgG1++++
Bovine IgG2++++++
Chicken IgY--
Dog IgG++++
Goat IgG1++++
Goat IgG2++++++
Guinea pig IgG++++
Hamster+NA
Horse IgG++++
Monkey IgG++++++
Porcine IgG++++++
Rabbit IgG++++++
Sheep IgG1++++
Sheep IgG2++++++

Table 1: Binding strength of protein A and G to different species of immunoglobulins (Igs) and their subclasses.

Incubation time

Increasing incubation times during immunoprecipitation can improve yield when working with low affinity antibodies. An incubation time of only 10 minutes is sufficient for most applications. Increasing the incubation time to 20-120 minutes can increase yield. Note that non-specific binding can increase with time.

Incubation temperature

For sensitive proteins, to avoid protein complex dissociation and minimize enzymatic activity e.g. when studying phosphorylation events, the isolation protocol including elution (2.5.B) may be run at 4°C.

Storage of Dynabeads®-Ab complex

For storage of Ab-conjugated Dynabeads®, we recommend using PBS (pH 7.4) with 0.01-0.1 % Tween-20 to  prevent aggregation.

References

Co-immunoprecipitation:

  • Lin-Lee Y-C et al. Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes. J.Biol.Chem. 2006;281: 18878- 18887
  • Haren L et al. NEDD1-dependent recruitment of the gamma-tubulin ring complex to the centrosome is necessary for centriole duplication and spindle assembly  J.Cell Biol. 2006;172:505-515
  • Pham LV et al. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 2005;106(12):3940- 3947
  • Catrein I et al. Experimental proof for a signal peptidase I like activity in Mycoplasma pneumoniae, but absence of a gene encoding a conserved bacterial type I SPase. FEBS J. 2005;272:2892- 2900

Purification of IgG from sera:

  • Kudva IT et al. Identification of a protein subset of the Anthrax spore immunome in humans immunized with the Anthrax vaccine adsorbed preparation. Infect. Immun. 2005;73:5685-5696

Chromatin immunoprecipitation:

  • Wu Z et al. Interleukin-21 receptor gene induction in human T cells Is mediated by T-cell receptor-induced Sp1 activity. Mol. Cell.Biol. 2005;25:9741- 9752 

Co-immunoprecipitation, automated washing:

  • Wan L et al. The survival of motor neurons protein determines the capacity for snRNP assembly: Biochemical deficiency in spinal muscular atrophy. Mol. Cell. Biol. 2005;25(13):5543-5551
100.06D.indd    Rev 000     May-5-2008